How Do I Get My Compound Into Phase I?
How Do I Get My Compound Into Phase I?

The primary challenge for pharmaceutical and biotechnology companies in developing their drugs is to carefully assess the relationship between efficacy and toxicity prior to entering into human clinical trials. By Dr. Scott E. Boley and Greg Ruppert

More Featured Articles


Bioanalytical Development Services Bioanalytical Development Services

Full capability is the approach INC Research/inVentiv Health takes to bioanalytical development regardless of your project size. Through our GLP-compliant laboratories, an extensive list of validated assays, custom assay services, knowledgeable scientists, and skilled technicians, INC Research/inVentiv Health Clinical provides bioanalytical services in all stages of drug development.

Clinical Research Clinical Research
Located on the campus of Cauvery Medical Centre in Bangalore, India, the 72-bed clinical facility contains separate areas for subject screening and blood draws, an on-site pharmacy and a state-of-the-art, fully equipped intensive care unit.
Early Phase
With a full scope of services from First in Human through Proof of Concept, PAREXEL's early phase operational teams are right where you need us.
Clinical Services Clinical Services

In today’s pressure-filled biopharmaceutical development environment, no company can afford to spend the $800M or more it takes to bring a product from the lab to the marketplace, only to have it fail in critical Phase III clinical trials.

Phase I Services Phase I Services
For the early stages of drug development, Rho provides packages for Phase I clinical trials that have predictable cost structures.
Therapeutic Areas Therapeutic Areas
Deep therapeutic knowledge and understanding of the key issues combined with clinical development experience drives more effective and efficient pathways to commercialization.
More Services & Products


More News